Literature DB >> 8985207

Immune responses associated with chronic fatigue syndrome: a case-control study.

A C Mawle1, R Nisenbaum, J G Dobbins, H E Gary, J A Stewart, M Reyes, L Steele, D S Schmid, W C Reeves.   

Abstract

An exploratory case-control study was conducted to assess whether the many reported differences in the immune function of chronic fatigue syndrome (CFS) patients are detectable in rigorously defined cases of CFS. Although many studies have reported differences between cases and controls in various measures of immune function, none of these differences were found in all studies. In this study, no differences were found in white blood cell numbers; immune complex, complement, or serum immunoglobulin levels; delayed type hypersensitivity and allergic responses; NK cell function; and proliferative responses to mitogens and antigens. Marginal differences were detected in cytokine responses and in cell surface markers in the total CFS population. However, when the patients were subgrouped by type of disease onset (gradual or sudden) or by how well they were feeling on the day of testing, more pronounced differences were seen.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985207     DOI: 10.1093/infdis/175.1.136

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

1.  Chronic fatigue syndrome is not associated with expression of endogenous retroviral p15E.

Authors:  I H Gelman; E R Unger; A C Mawle; R Nisenbaum; W C Reeves
Journal:  Mol Diagn       Date:  2000-06

Review 2.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

4.  Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults.

Authors:  Cindy M Chang; Joan L Warren; Eric A Engels
Journal:  Cancer       Date:  2012-05-30       Impact factor: 6.860

5.  Detection of immunologically significant factors for chronic fatigue syndrome using neural-network classifiers.

Authors:  S J Hanson; W Gause; B Natelson
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

6.  Double-blind, randomized study of the effects of influenza vaccination on the specific antibody response and clinical course of patients with chronic fatigue syndrome.

Authors:  K M Sleigh; D G Danforth; R T Hall; J A Fleming; H G Stiver
Journal:  Can J Infect Dis       Date:  2000-09

7.  Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.

Authors:  M J Robertson; R S Schacterle; G A Mackin; S N Wilson; K L Bloomingdale; J Ritz; A L Komaroff
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

8.  Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls.

Authors:  A S Bradley; B Ford; A S Bansal
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

9.  High levels of type 2 cytokine-producing cells in chronic fatigue syndrome.

Authors:  A Skowera; A Cleare; D Blair; L Bevis; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

10.  Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome.

Authors:  Q Zhang; X D Zhou; T Denny; J E Ottenweller; G Lange; J J LaManca; M H Lavietes; C Pollet; W C Gause; B H Natelson
Journal:  Clin Diagn Lab Immunol       Date:  1999-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.